Search Results

Minister of Health Edwin Dikoloti says the injections, given every two months, are more convenient than daily pills, which patients sometimes skip.

Clinical trial of very early treatment of newborns was designed to replicate the case of the Mississippi Baby reported in 2013, who experienced a more than two-year remission of HIV.

Antiretrovirals developed at Johns Hopkins that block nSMase2 and PDDC promise the potential for treating HIV by not only suppressing HIV replication but also by killing the cells that are infected.

Research suggests that antiretroviral drugs called TAF and TDF directly reduce energy production by mitochondria, structures inside cells that generate the power that cells use to function.

A new LED-powered photothermal therapy uses nanotechnology to target and destroy cancer cells while sparing healthy tissue.

Scientists uncover why leukemia drug venetoclax loses effectiveness and explore ways to overcome resistance.